ITRAT ZEHRA-RAZA: Open Payments
NPI 1275200271 · FOXBORO, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,178 in 106 payments from 27 companies in 2025. Trend: 2023 $1,081 · 2024 $1,612 · 2025 $2,178
Food & beverage: $2,169Education: $10
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. | 15 | $338 |
| ABBVIE INC. | 18 | $327 |
| Lundbeck LLC | 14 | $251 |
| SK Life Science, Inc. | 8 | $240 |
| Biogen, Inc. | 8 | $168 |
| PFIZER INC. | 5 | $90 |
| Alexion Pharmaceuticals, Inc. | 3 | $62 |
| ARGENX US, INC. | 2 | $57 |
| Amgen Inc. | 3 | $55 |
| CATALYST PHARMACEUTICALS, INC. | 2 | $50 |
Products named: VYEPTI, QULIPTA, TYSABRI, NURTEC ODT, LEQEMBI, UBRELVY, ULTOMIRIS, VYVGART HYTRULO.
Industry payments across MA — which companies pay providers there.
